Loading…
Loading…
Tender Value
₹29.8 Cr
Closing Date
16 Jul 2021, 11:00 amClosed
GM(MM)/HOD
GM(MM)/HOD SECL HQ Bilaspur, (C.G.)
RATE CONTRACT FOR SUPPLY OF MEDICINES UNDER GROUP B FOR A PERIOD OF 2 YEARS FOR AREAS OF SECL IN CG AND MP.
2021_SECL_210032_1
SECL/BSP/MMW/SW/GROUP B MEDICINE/21 Dt. 23/06/21
Open Tender
Medicines
Tender cum Auction
75 days
SECL HQ, (C.G.)
Please refer tender documents
8 documents required · 8 mandatory
Exempted
27 Apr 2022
24 Jun 2021
17 Jul 2021
24 Jun 2021
16 Jul 2021
24 Jun 2021
24 Jun 2021 - 1 Jul 2021
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 0 | ITEM DESCRIPTION | - | - | - | - |
| 1 | Choline Salicylate BP 9 % w/v + Benzalkonium Chloride Solution IP 0.02 % w/v | 1 | Nos | - | - |
| 2 | Methyl Salicylate 30 % + Camphor 4 % + Menthol 10 % | 1 | Nos | - | - |
| 3 | S(+)Etodolac 5% w/w + Camphor 4% w/w + Menthol 10% w/w + Methyl Salicylate 5% w/w + Linseed Oil 3% w/w | 1 | Nos | - | - |
| 4 | Flurbiprofen IP 5 % w/w | 1 | Nos | - | - |
| 5 | Diclofenac Diethylamine BP 2.32 % w/v Methyl Salicylate IP 10 % w/v Menthol IP 5.00 % w/v topical solution | 1 | Nos | - | - |
| 6 | Nifedipine 0.3%W/W + Lidocaine 1.5%W/W In Organogel Base 30gm | 1 | Nos | - | - |
| 7 | Halothane 200 ml. | 1 | Nos | - | - |
| 8 | Isoflurane 100ml | 1 | Nos | - | - |
| 9 | Sevoflurane | 1 | Nos | - | - |
stage.html
html • 0.03 MB
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.04 MB
BOQ_216328.xls
BOQ Document • 0.74 MB
TPS_216328.xls
BOQ Document • 2.74 MB
79201346.pdf
Tender Document • 1.28 MB
79201350.html
Tender Document • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .